HydraFacial LLC v. Luvo Medical Technologies

This patent infringement litigation was initiated by HydraFacial LLC against Luvo Medical Technologies in the U.S. District Court for the District of Utah (Case No. 2:24-cv-00587). HydraFacial LLC, a subsidiary of The Beauty Health Company (NASDAQ: SKIN), is a prominent operating company in the beauty health sector, known for its patented Vortex-Fusion® technology utilized in non-invasive hydradermabrasion treatments. Luvo Medical Technologies Inc. is also an operating company, specializing in providing aesthetic technologies like its BELA MD Skin Health Platform to medical professionals and patients, aiming to make medical aesthetics more accessible. The suit also named Healthcare Markets, Inc. (doing business as Powered by MRP) and foreign manufacturer Eunsung Global Corp. as defendants.

The alleged infringement stemmed from Healthcare Markets' sale of Luvo's hydrodermabrasion systems, with the "BELA MD Skin Health Platform" being a key product under scrutiny. HydraFacial initially asserted infringement of five of its patents, with U.S. Patent No. 9,550,052 being specifically identified in the case information. This patent generally covers foundational aspects of skin treatment system mechanics, particularly hydradermabrasion technology that involves the use of a unique delivery system, such as spiral-designed HydroPeel® tips and vacuum action, to cleanse, exfoliate, extract, and infuse serums into the skin.

The case, filed on August 16, 2024, was presided over by District Judge Tena Campbell. While the District of Utah is not among the highest volume patent litigation venues, it has established local patent rules, and local counsel often assist national firms in such disputes. The case resolved relatively quickly, terminating on August 8, 2025, with a consent judgment and permanent injunction against the defendant. This litigation is notable as it underscores HydraFacial's aggressive enforcement strategy to protect its intellectual property in the competitive medical aesthetics device market. Furthermore, the district court case was initially stayed due to a parallel investigation at the International Trade Commission (ITC), where HydraFacial sought an exclusion order against Luvo and other entities for infringing hydrodermabrasion systems, highlighting a comprehensive multi-forum enforcement approach.

The patent infringement litigation HydraFacial LLC v. Luvo Medical Technologies (Case No. 2:24-cv-00587, U.S. District Court for the District of Utah) concluded with a consent judgment and permanent injunction.

Here is a chronological summary of the key legal developments and outcome:

Filing & Initial Pleadings:

• Complaint Filed (2024-08-16): HydraFacial LLC filed a complaint against Luvo Medical Technologies Inc., Clarion Medical Technologies Inc., Eunsung Global Corp., and Healthcare Markets Inc. doing business as Powered by MRP. The complaint alleged infringement of five of HydraFacial's patents related to hydrodermabrasion systems, including U.S. Patent No. 9,550,052.
• The case was assigned to District Judge Tena Campbell.

Pre-Trial Motions and Stays:

• Case Stayed (Date not specified, but occurred early): The district court case was initially stayed due to a corresponding investigation by the U.S. International Trade Commission (ITC), referred to as the "ITC Luvo Matter" (Inv. No. 337-TA-1417).
• Settlement with Luvo and Healthcare Markets (2025-03-17): HydraFacial signed a settlement agreement with defendants Luvo Medical Technologies and Healthcare Markets Inc. This settlement led to the termination of the ITC investigation as to these parties.
• Joint Motion to Stay (prior to 2025-07-30): HydraFacial LLC and defendant Eunsung Global Corp. filed a joint notice of settlement and a joint motion to stay, indicating they had reached a settlement in principle to resolve all issues in the case. The court granted this motion, staying all deadlines until August 29, 2025.

Discovery Milestones:

• Discovery Motion Administratively Terminated (prior to 2025-07-30): A "Short Form Discovery Motion to Compel re: Initial Disclosures, Judge Campbell's Patent Rule 4.A.(2) Document Production, and Interrogatory Responses" filed by HydraFacial was administratively terminated due to the settlement and stay.

Settlement, Dismissal, and Judgment:

• Joint Motion for Consent Judgment and Permanent Injunction (prior to 2025-08-08): Plaintiff HydraFacial LLC filed a Joint Motion for Entry of Consent Judgment and Joint Motion for Permanent Injunction.
• Final Consent Judgment and Permanent Injunction (2025-08-08): A Final Consent Judgment and Permanent Injunction was entered against Eunsung Global Corp., formally closing the case.
• Case Closed (2025-08-08): The case was officially terminated and closed.

Parallel PTAB IPR Proceedings:

• IPR Filed on U.S. Patent No. 9,550,052 (2025-03-11): Eunsung Global Corp. filed an inter partes review (IPR) petition against U.S. Patent No. 9,550,052, designated as IPR2025-00445, before the Patent Trial and Appeal Board (PTAB). The status or outcome of this specific IPR could not be determined from the available information. While Eunsung was involved in other IPRs concerning different HydraFacial patents, the IPR on the '052 patent was specifically initiated by Eunsung.

Counsel of Record for Plaintiff HydraFacial LLC

The following attorneys have represented HydraFacial LLC in HydraFacial LLC v. Luvo Medical Technologies, Case No. 2:24-cv-00587, in the U.S. District Court for the District of Utah:

• D. Craig Parry

  • Role: Local Counsel
  • Firm: Parsons Behle & Latimer, Salt Lake City, Utah
  • Note on experience: Parsons Behle & Latimer has an intellectual property litigation practice with experience trying cases across the United States, including patent infringement cases. The firm has handled appeals before the Federal Circuit Court of Appeals and has secured victories for clients in patent disputes involving various technologies.

• Benjamin J. Everton

  • Role: Lead Counsel (admitted pro hac vice)
  • Firm: Womble Bond Dickinson (US) LLP, Atlanta, Georgia.
  • Note on experience: Mr. Everton is listed as an attorney for Patent Owner HydraFacial LLC in a related IPR proceeding, and Womble Bond Dickinson has a strong intellectual property litigation practice, frequently representing clients in patent lawsuits in federal courts, including in active patent litigation venues. The firm's patent litigators hold degrees in a wide variety of technical disciplines and have experience with both district court and USPTO proceedings.

• Christian D. Boettcher

  • Role: Lead Counsel (admitted pro hac vice)
  • Firm: Womble Bond Dickinson (US) LLP, Atlanta, Georgia.
  • Note on experience: Womble Bond Dickinson (US) LLP's intellectual property litigation team handles complex IP cases in federal courts nationwide, including asserting and defending against patent infringement claims. The firm has a deep bench of patent professionals with diverse technical backgrounds.

• Ali S. Razai

  • Role: Lead Counsel
  • Firm: Womble Bond Dickinson (US) LLP, Orange County, California.
  • Note on experience: Mr. Razai is listed as an attorney for Patent Owner HydraFacial LLC in a related IPR proceeding and in other related district court cases. Womble Bond Dickinson has a robust IP practice with extensive experience in patent litigation and procurement across various industries, including life sciences.

• Peter J. Gluck

  • Role: Lead Counsel (admitted pro hac vice)
  • Firm: Patnstr, APC, Laguna Niguel, California.
  • Note on experience: Mr. Gluck is an intellectual property lawyer with extensive experience in patent procurement, policing, and intellectual property portfolio management. He has a history of counseling companies on patent portfolio generation and valuation, with a focus on avoiding litigation through creative solutions. He has spent time in-house as chief IP counsel and assistant general counsel for medical device companies.

In the patent infringement case of HydraFacial LLC v. Luvo Medical Technologies (2:24-cv-00587), the following attorneys represented the defendant(s):

For Defendant Luvo Medical Technologies:

• Jonathan P. O'Brien, Ph.D. - Lead Counsel

  • Firm: Honigman LLP (Kalamazoo, Michigan office)
  • Note: Dr. O'Brien is chair of Honigman's intellectual property department and has over 20 years of experience assisting companies on global IP portfolio procurement and enforcement strategies, particularly in the life sciences, biotechnology, nutraceutical, and medical device industries. He was recognized as the LMG Life Sciences 2023 Patent Strategy Attorney of the Year – Midwest.

• Spencer F. Young - Local Counsel

  • Firm: Strong & Hanni (Salt Lake City, Utah office)
  • Note: Spencer Young began his legal career as a litigator, handling complex commercial and real estate disputes. While he now focuses on transactional law (mergers and acquisitions, data privacy), he still litigates for clients on occasion and has experience in the courtroom.

• Raymond H. Johnson - Of Counsel

  • Firm: The Johnson IP Law Firm (Needham, Massachusetts office)
  • Note: Ray Johnson is a registered patent attorney with over 35 years of IP legal experience, including patent, trademark, copyright, and trade secret litigation, with a focus on medical devices, among other technical fields.

• Jonathan O'Connell - Of Counsel

  • Firm: O'Connell Law Office (Arlington, Massachusetts)
  • Note: Thomas O'Connell of O'Connell Law Office has prosecuted hundreds of successful patent applications globally, including in medical devices, and has litigation experience with patent infringement. Note: There appear to be multiple attorneys named Jonathan O'Connell or Jon O'Connell; the experience listed here is for Thomas O'Connell of O'Connell Law Office, which is an IP boutique firm. Other Jonathan O'Connells found in search results focus on corporate law, venture capital, or personal injury litigation.

It is worth noting that Luvo Medical Technologies is a Canadian company and the complaint also named Clarion Medical Technologies, Inc. (also Canadian), Eunsung Global Corp. (foreign manufacturer), and Healthcare Markets, Inc. (doing business as Powered by MRP) as defendants.